Prognostic factors in patients undergoing radical surgery and intraoperative radiotherapy for gynecologic malignancies recurring at the pelvic sidewall;Prognosefaktoren bei der planung organübergreifender debulkingoperation und intraoperativer strahlentherapie bei beckenwandrezidiven gynäkologischer karzinome

Geburtshilfe und Frauenheilkunde

Volumn 62, Issue 6, 2002, Pages 554-559

  Solomayer, E F ^a   Wallwiener, D ^a   Sinn, H P ^c   Becker, S ^a   Grischke, Eva Maria ^d   Bastert, G ^b   Emig, R ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Klinikum Schwabing   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CELL PROLIFERATION; EVALUATION; FEMALE; GENE EXPRESSION; GYNECOLOGIC CANCER; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; ONCOGENE NEU; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0036305328     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-32425     Document Type: Article

References (59)

1. The usefulness of intraoperative radiation therapy in the treatment of pelvic recurrence of cervical cancer
2. The p53 tumor-suppressor gene in human breast cancer
3. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer
4. Expression of epidermal growth factor receptor and HEER-2/neu in normal and neoplastic cervix, vulva, and vagina
5. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer
6. Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease
7. Effect of neoadjuvant chemotherapy on Ki67 labelling index, c-erb-2 expression and steroid hormone receptor status in human breast tumours
8. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma
9. Intraoperative radiotherapy. A positive view
10. Role of three cancer "master genes" p53, bcl2 and c-myc on the apoptotic process
11. Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status
12. Radiotherapy for carcinoma of the cervix recurrent after surgery
13. External vs. interstitial irradiation in unresectable recurrent cancer of the cervix
14. Tumor angiogenesis in node-negative breast carcinomas - Relationship with epidermal growth factor receptor, estrogen receptor, and survival
15. Radiobiology and cell cycle
16. Intraoperative radiation therapy in gynecological cancer: Mayo clinic experience
17. Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas
18. Place de la radiotherapie peroperatoire dans le traitement des cancers de l'uterus. Experience lyonnaise preliminaire
19. Intraoperative electron beam radiation therapy for gynecological malignancies
20. Angiogenese beim mammakarzinom - Quantifizierung der gefäßdichte mittels morphometrie als neuer prognosefaktor
21. Nonresectable recurrent pelvic neoplasm. Outcome in patients explored for pelvic exenteration
22. p53 expression in epithelial ovarian neoplasms: Relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry
23. Eine neue experimentelle methode zur behandlung yon beckenwandrezidiven gynäkologischer malignome
24. Five-year experience with combinated operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall
25. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
26. Parametrial interstitial brachytherapy for advanced or recurrent pelvic malignancy: The Harvard/Standford experience
27. Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen
28. Determination of proliferation index in advanced ovarian cancer using quantitative image analysis
29. neu expression in human lung adenocarcinomas predicts shortened survival
30. Tolerance of peripheral nerve to intraoperative radiotherapy (IORT) clinical and experimental studies
31. Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresis
32. Primary chemotherapy in breast invasive carcinoma: Predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erb-2, MiB1, pS2 and GSTπ
33. Intraoperative radiation therapy in recurrent carcinoma of the uterine cervix: Report of the french intraoperative group on 70 patients
34. Overexpression and mutation of p53 in epithelial ovarian cancer
35. Overexpression of the oncogene c-erb-2 in primary ovarian cancer: Evaluation of the prognostic value in a Cox proportional hazards multiple regression
36. p53 mutation is a common genetic event in ovarian carcinoma
37. Transition of Ki-67 index of uterine cervical tumors during radiation therapy. Immunohistochemical study
38. Differential values of Ki-67 index and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer
39. Stability of HER-2/neu expression over time and at multiple metastatic sites
40. Improved immunohistochemical detection of p53 protein in paraffin-embedded tissues reveals elevated levels in most head and neck and lung carcinomas: Correlation with clinicopathological parameters
41. Prognostic value of Ki-67 immunolabelling in primary operable breast cancer
42. The Bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients
43. Experimental and clinical studies with intraoperative radiotherapy
44. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
45. Studies of the HER-2/NEU proto-oncogene in human breast and ovarian cancer
46. Outcome of recurrent cervical carcinoma following definitive irradiation
47. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
48. Breast cancer heterogeneity: Evaluation of clonality in primary and metastatic lesions
49. HER-2/neu oncogene protein and prognosis in breast cancer
50. Analysis of c-erb-2 expression in breast carcinomas with clinical follow-up
51. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas
52. Intraoperative radiation therapy in the treatment of pelvic malignancies: A preliminary report
53. Proliferation index as a prognostic marker in breast cancer
54. Heterogeneity of X-ray cytotoxicity in proliferating and quiescent murine mammary carcinoma cells
55. Organübergreifendes debulking in kombination mit intraoperativer strahlentherapie im multimodalen therapiespektrum von beckenrezidiven
56. Site of recurrence of cervical cancer after radical hysterectomy
57. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
58. Ki67 immunostaining in human breast tumors and its relationship to prognosis
59. Immunhistochemical detection of proliferating tumor cells in cervical cancer using monoclonal antibody Ki-67